Chapter 6
Chapter 6
Chapter 6
Overall Conclusions
108
Overall Conclusions
A rapid, sensitive and accurate method was to develop and validate for
simultaneous estimation of Lamivudine, Tenofovir DF and Dolutegravir in drug
product by liquid chromatography. The chromatographic separation was achieved on
column (Luna C8 150*4.6 mm) at ambient temperature .The separation was achieved
employing a mobile phase consists of 0.1%v/v TFA in water and Acetonitrile with simple
gradient programme. The flow rate was maintained as 1.0 mL/min and ultra violet
detector at 260 nm was used. The average retention time for Lamivudine, Tenofovir DF
and Dolutegravir found to be 2.023 min, 5.330 min and 7.673. The proposed method
was validated for selectivity, precision, linearity and accuracy. All validation parameters
109
Overall Conclusions
were within the acceptable range. The assay methods were found to be linear from 75.0 –
225.0 μg/mL for Lamivudine, 75.0 – 225.0 μg/mL of Tenofovir DF and 12.5 – 37.50
μg/mL of Dolutegravir. From the results, the proposed method is more acceptable and
cost effective and it can be effectively applied for routine analysis in research institutions,
quality control department in industries and approved testing laboratories.
110
Overall Conclusions
μm column. The gradient LC method employs solution A and solution B as mobile phase.
The solution A contains aqueous 0.1% TFA in Water and solution B contains acetonitrile
as Gradient mode. The HPLC method was developed and validated with respect to
linearity, accuracy, precision, specificity and ruggedness. Further, the simple, precise,
accurate and high resolution and shorter retention time makes this method more
acceptable and cost effective and it can be effectively applied for routine analysis in
research institutions, quality control department in meant in industries, approved testing
laboratories for the determination of Fosamprenavir drug.
A new, simple, rapid, selective, precise and accurate isocratic reverse phase high
performance liquid Chromatography assay method has been developed for estimation of
Calcium dobesilate in tablet formulations. The separation was achieved by using column
Waters symmetry C18 (4.6x150mm), 5μ (Make: Waters), in mobile phase consisted of
pH 2.5 Phosphate buffer Acetonitrile and in the ratio of (95:5, v/v). The flow rate was 1.0
mL.min-1 and column oven temperature 30°C, the injection volume was 20 μL the
separated Calcium dobesilate was detected using UV detector at the wavelength of 300
nm. The retention time of Calcium dobesilate, was noted to be 4.22 min, indicative of
rather shorter analysis time. The method was validated as per ICH guidelines. The
proposed method was applied for determination of Calcium dobesilate in marketed
formulation. Hence, the developed RP-HPLC method was found to be satisfactory and
could be used for the routine analysis of Calcium dobesilate in tablet dosage form.
111